2. NF-κB
  3. NF-κB
  4. Hesperidin methylchalcone

Hesperidin methylchalcone (Hesperidin methyl chalcone) is an orally active flavonoid that has analgesic, anti-inflammatory and antioxidant properties. Hesperidin methylchalcone exhibits vasoprotective activity. Hesperidin methylchalcone inhibits oxidative stress, cytokine production and NF-κB activation. Hesperidin methylchalcone can be used for the research of gout disease.

For research use only. We do not sell to patients.

Hesperidin methylchalcone Chemical Structure

Hesperidin methylchalcone Chemical Structure

CAS No. : 24292-52-2

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 USD 33 In-stock
Solution
10 mM * 1 mL in DMSO USD 33 In-stock
Solid
1 g USD 30 In-stock
5 g   Get quote  
10 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Hesperidin methylchalcone Related Antibodies

Top Publications Citing Use of Products

1 Publications Citing Use of MCE Hesperidin methylchalcone

View All NF-κB Isoform Specific Products:

View All Isoforms
NF-κB NF-κB1/p50 RelA/p65 RelB c-Rel

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Hesperidin methylchalcone (Hesperidin methyl chalcone) is an orally active flavonoid that has analgesic, anti-inflammatory and antioxidant properties. Hesperidin methylchalcone exhibits vasoprotective activity. Hesperidin methylchalcone inhibits oxidative stress, cytokine production and NF-κB activation. Hesperidin methylchalcone can be used for the research of gout disease[1][2].

IC50 & Target[1]

NF-κB

 

In Vivo

Hesperidin methylchalcone (0.03-3 mg/kg, i.p., once time) inhibits the elevation of renal dysfunction markers (urea and creatinine) induced by SDCF in mice in a dose-dependent manner[1].
Hesperidin methylchalcone (3 mg/kg, i.p., once time) can effectively counteract the oxidative stress induced by SDCF in renal tissue of mice[1].
Hesperidin methylchalcone (3 mg/kg, i.p., once time) reduces SDCF-induced renal histopathology, swelling and tubular cells cytotoxicity in mice[1].
Hesperidin methylchalcone (3-30 mg/kg, p.o., once time) reduces in a dose-dependent manner the MSU-induced hyperalgesia, edema, and leukocyte infiltration in mice[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Swiss mice[1]
Dosage: 3 mg/kg
Administration: i.p., once time
Result: Increased the levels of FRAP and ABTS, and reduced concentration of TBARS.
Reduced IL-6, IFN-γ, and IL-33 levels in plasma.
Increased the FRAP, ABTS, and GSH levels, reduced Keap1, and inhibited lipid peroxidation in kidneys.
Reduced IL-1β, IL-6, IFN-γ, and IL-33, and increased IL-10 levels in renal tissue.
Increased Nrf2, Ho-1 and Nqo1 mRNA expression.
Animal Model: Swiss mice[2]
Dosage: 3-30 mg/kg
Administration: p.o., once time
Result: Inhibited MSU-induced infiltration of LysM-eGFP+ cells and synovitis at the dose of 30 mg/kg.
Reduced IL-1β, TNF-α, IL-6, and IL-10 levels, and increased GSH, FRAP, and ABTS at the dose of 30 mg/kg.
Inhibited MSU-induced NF-κB activation, gp91phox and NLRP3 inflammasome components mRNA expression in vivo (NLRP3, ASC, pro-caspase-1, and pro-IL-1 β).
Induced Nrf2/HO-1 mRNA expression.
Molecular Weight

624.59

Formula

C29H36O15
CAS No.
Appearance

Solid

Color

Light brown to yellow

SMILES

COC1=C(C(/C=C/C2=CC(O)=C(OC)C=C2)=O)C(O)=CC(O[C@H](O3)[C@H](O)[C@@H](O)[C@H](O)[C@H]3CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)=C1
Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.
Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

DMSO : 50 mg/mL (80.05 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.6011 mL 8.0053 mL 16.0105 mL
5 mM 0.3202 mL 1.6011 mL 3.2021 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.08 mg/mL (3.33 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.08 mg/mL (3.33 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
% 
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.6011 mL 8.0053 mL 16.0105 mL 40.0263 mL
5 mM 0.3202 mL 1.6011 mL 3.2021 mL 8.0053 mL
10 mM 0.1601 mL 0.8005 mL 1.6011 mL 4.0026 mL
15 mM 0.1067 mL 0.5337 mL 1.0674 mL 2.6684 mL
20 mM 0.0801 mL 0.4003 mL 0.8005 mL 2.0013 mL
25 mM 0.0640 mL 0.3202 mL 0.6404 mL 1.6011 mL
30 mM 0.0534 mL 0.2668 mL 0.5337 mL 1.3342 mL
40 mM 0.0400 mL 0.2001 mL 0.4003 mL 1.0007 mL
50 mM 0.0320 mL 0.1601 mL 0.3202 mL 0.8005 mL
60 mM 0.0267 mL 0.1334 mL 0.2668 mL 0.6671 mL
80 mM 0.0200 mL 0.1001 mL 0.2001 mL 0.5003 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Hesperidin methylchalcone Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Hesperidin methylchalcone24292-52-2NF-κBNuclear factor-κBNuclear factor-kappaBSDCFMSUorally activegout diseasevasoprotectivecytokineoxidativeanalgesicanti-inflammatoryantioxidantInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Hesperidin methylchalcone
Cat. No.:
HY-126382
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (393 KB) Français - FR (393 KB) Deutsch - DE (393 KB) Norwegian - NO (393 KB) Español - ES (393 KB) Swedish - SV (393 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.